Surmodics Stock

Surmodics Stock-Based Compensation

Delisted·Nov 18, 2025

The Stock-Based Compensation (SBC) of Surmodics (SRDX) as of Aug 12, 2026 is 8.22 M USD. In the previous year, Stock-Based Compensation (SBC) was 7.61 M USD — a change of 8.05% (higher).

Stock-Based Compensation

8.22 MUSD

YoY

8.05%

Last updated:

Stock-Based Compensation (SBC) of Surmodics is 2026 8.22 M USD. Stock-Based Compensation (SBC) of Surmodics was 2025 7.61 M USD. It decreases by 8.05% higher compared to the previous year.
Access this data via the Eulerpool API

Surmodics Stock analysis

What does Surmodics do? Surmodics Inc is an American company specializing in medical technology, based in Eden Prairie, Minnesota. They focus on developing and commercializing technologies to improve disease diagnosis and treatment. The company offers a wide range of medical devices and solutions for various medical applications, including cardiology, radiology, oncology, ophthalmology, and pharmaceutical development. Surmodics operates in three main business areas: medical devices, hollow fiber technology, and bioactive coatings. Their products are designed to meet the specific needs of customers and medical applications. Surmodics has a strong global presence and has expanded through strategic acquisitions in recent years, particularly in the pharmaceutical development and hollow fiber technology sectors. Surmodics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Surmodics stock

Stock-Based Compensation (SBC) of Surmodics is 8.22 M USD in 2026.

Stock-Based Compensation (SBC) of Surmodics changed from 7.61 M USD to 8.22 M USD, representing a 8.05% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) Surmodics since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s Surmodics historically and in real time.

Access this data via the Eulerpool API

Cash Flow — Surmodics

All Key Metrics — Surmodics